Evidence map›Paper›PMID 32653043›Full record

ArticleCritical care (London, England)2020

Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.

Zhinian Guo, Yunlong Chen, Xiaoyu Luo, Xiaolong He, Yong Zhang, Jiang Wang

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Mesenchymal Stem Cells in the Treatment of COVID-19.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Stem cell-based therapy for human diseases.Signal transduction and targeted therapy · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhinian GuoDepartment of Cardiology, Xinqiao Hospital of Army Medical University, 183 Xinqiao Street, Chongqing, 400037, China.
Yunlong ChenDepartment of Cardiology, Xinqiao Hospital of Army Medical University, 183 Xinqiao Street, Chongqing, 400037, China.
Xiaoyu LuoDepartment of Cardiology, Xinqiao Hospital of Army Medical University, 183 Xinqiao Street, Chongqing, 400037, China.
Xiaolong HeDepartment of Cardiology, Xinqiao Hospital of Army Medical University, 183 Xinqiao Street, Chongqing, 400037, China.
Yong ZhangDepartment of Cardiology, Xinqiao Hospital of Army Medical University, 183 Xinqiao Street, Chongqing, 400037, China.
Jiang WangDepartment of Cardiology, Xinqiao Hospital of Army Medical University, 183 Xinqiao Street, Chongqing, 400037, China. 504641821@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mesenchymal Stem Cell TransplantationAgedCoronavirus InfectionsCOVID-19FemaleHumansMaleMiddle AgedPandemicsPneumonia, ViralSeverity of Illness IndexTreatment OutcomeUmbilical Cord

Identifiers

PMID32653043
PMCPMC7351637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.